BioCentury This Week

Ep. 253 - IPOs, GLP-1 & Obesity, AI & Biotech

Sep 17, 2024
Biotech IPOs are on the rise, with three companies making successful NASDAQ debuts. The discussion dives into the parallels between GLP-1 treatments for obesity and the successful PD-1 cancer drugs. There's also a thrilling exploration of how AI is transforming biopharma, from data quality to innovative strategies. Recent conferences shed light on future trends in obesity research and the evolving investment landscape for tech and biotech firms. Tune in for insights that blend market dynamics and groundbreaking scientific developments!
Ask episode
Chapters
Transcript
Episode notes